NDC00015-0549-41: CYCLOPHOSPHAMIDE FOR INJECTION.
The CYCLOPHOSPHAMIDE FOR INJECTION is a the manufacturer industrial component. Key specifications include physical_form: FREEZE-DRIED POWDER, features_provided: STERILE, primary_container_type: VIAL, protective_storage_feature: ANTINEOPLASTIC DRUG, medical_designation_and_grade: UNITED STATES PHARMACOPEIA, warning_and_caution_statements: CHEMOTHERAPEUTIC AGENT; HANDLE WITH CARE. This part is cataloged in the U.S.
Government catalog under NSN 6505-01-219-3900, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| physical_form | FREEZE-DRIED POWDER |
| features_provided | STERILE |
| primary_container_type | VIAL |
| protective_storage_feature | ANTINEOPLASTIC DRUG |
| medical_designation_and_grade | UNITED STATES PHARMACOPEIA |
| warning_and_caution_statements | CHEMOTHERAPEUTIC AGENT; HANDLE WITH CARE |
| total_primary_container_quantity | 6 |
| primary_container_content_quantity | 2.000 GRAMS OF ACTIVE INGREDIENT G |
| active_medicament_medicinal_strength | 2.000 GRAMS CYCLOPHOSPHAMIDE ACTIVE INGREDIENT G |
| part_name_assigned_by_controlling_agency | CYCLOPHOSPHAMIDE FOR INJECTION USP 2GM VIAL FREEZE DRIED POWDER 6S |
| NSN | 6505-01-219-3900 |
| PRIMARY CONTAINER CONTENT QUANTITY | 2.000 GRAMS OF ACTIVE INGREDIENT G |
| MEDICAL DESIGNATION AND GRADE | UNITED STATES PHARMACOPEIA |
| FEATURES PROVIDED | STERILE |
| PRIMARY CONTAINER TYPE | VIAL |
| PHYSICAL FORM | FREEZE-DRIED POWDER |
| PROTECTIVE STORAGE FEATURE | ANTINEOPLASTIC DRUG |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | CYCLOPHOSPHAMIDE FOR INJECTION USP 2GM VIAL FREEZE DRIED POWDER 6S |
| WARNING AND CAUTION STATEMENTS | CHEMOTHERAPEUTIC AGENT; HANDLE WITH CARE |
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | 2.000 GRAMS CYCLOPHOSPHAMIDE ACTIVE INGREDIENT G |
| TOTAL PRIMARY CONTAINER QUANTITY | 6 |